Norepinephrine Bitartrate Injection 16 mg per 250 mL added to 0.9% Sodium Chloride, 16 mg, 250 mL...

FDA Recall #D-0707-2022 — Class II — March 14, 2022

Recall #D-0707-2022 Date: March 14, 2022 Classification: Class II Status: Terminated

Product Description

Norepinephrine Bitartrate Injection 16 mg per 250 mL added to 0.9% Sodium Chloride, 16 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-476-15

Reason for Recall

Defective container

Recalling Firm

Athenex Pharma Solutions, LLC — Clarence, NY

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

5,320 bags

Distribution

USA nationwide.

Code Information

Lot #: F2101634, Exp 3/30/22; F2101665, F2101666, Exp 4/02/22; F2101788, F2101789, Exp 4/26/22; F2101811, F2101812, F2101815, Exp 4/29/22

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls